BridgeBio Pharma, Inc. P/E ratio

P/E ratio of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/E ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its earnings per share. A low P/E ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. P/E ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Current P/E ratio of BridgeBio Pharma, Inc. is 0.0 (as of December 31, 2021)
  • P/E ratio for the quarter ending September 30, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly P/E ratio decreased by NaN%
  • Annual P/E ratio for 2021 was 0.0 (a NaN% decrease from previous year)
  • Annual P/E ratio for 2020 was 0.0 (a NaN% decrease from previous year)
Visit stockrow.com/BBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/E ratio of BridgeBio Pharma, Inc.

Most recent P/E ratioof BBIO including historical data for past 10 years.

Interactive Chart of P/E ratio of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. P/E ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – 0.0 0.0 0.0 –
2021 0.0 0.0 0.0 0.0 0.0
2020 – – 0.0 0.0 0.0
2019 0.0 0.0 – – 0.0

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com